AWA Point
Category: Insights
Clarifying the patentability of medical use inventions in China
At the end of 2019, the new Coronavirus (2019-nCoV) emerged. It has gone on to infect millions of people
EPO rules plants and animals exclusively obtained by essentially biological processes not patentable
It has been clear that essentially biological processes for the production of plants or animals are explicitly excluded from
What patent protection does Gilead’s COVID-19 treatment Remdesivir have?
On 29 April 2020 Gilead announced that its drug Remdesivir has a positive effect in the treatment of COVID-19
WIPO panel finds that Danish start-up Acubit engaged in reverse domain name hijacking
Technology start-up Acubit claimed that Danish trademark rules and practice should assign domain names to the relevant trademark owner.
China-Norway patent prosecution highway pilot launches
A memorandum between China and Norway will speed up and reduce costs when applying for patents On April 1,
Why China’s computer software copyright registrations are increasing
Statistics show a sharp rise in copyright registrations for computer software in China, which can provide an additional layer
China further curbs bad-faith trademark applications
Provisions enacted alongside China’s recently amended Trademark Law seek to effectively regulate bad-faith trademark filings including penalties through the
Balmain case highlights risk of using specialised public with low distinctive character marks
Balmain’s appeal to the General Court demonstrates that applicants should not rely on a specialised public for goods or services
Protecting against digital trademark infringement
Over the past few years, digitalisation has brought immense business opportunities with new commerce concepts and marketing possibilities constantly
German Court finds Unified Patent Court legislation unconstitutional
Today, the court tasked with upholding Germany’s constitution, the Bundesverfassungsgericht, has issued its long-awaited decision on a complaint against